In a recent study posted to the bioRxiv* preprint server, researchers assessed the impact of Bacillus Calmette-Guérin (BCG) vaccination on the protection provided by severe acute respiratory syndrome ...

Administering the Bacillus Calmette-Guérin (BCG) vaccine during the active phase of COVID-19 may help protect against the development of long COVID. A phase 3 clinical trial initiated in early 2020 ...

In a group of older patients with a median of two comorbidities, COVID infections were reported in 4.2% patients who received the BCG vaccine compared with 3.7% of those given placebo (HR 1.12, 95% CI ...

The bacillus Calmette–Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses did not ...

Infants who received BCG [bacille Calmette-Guérin] vaccination at birth had protection against tuberculosis into early childhood, but that protection largely disappeared in only a few years, according ...

Bacillus Calmette-Guérin (BCG) is one of the world’s oldest and most widely used vaccines. It was developed in the early 20th century to provide protection from tuberculosis. Surprisingly, this ...

The world may have another tool with which to fight the effects of the Covid-19 virus. A new study published in Cell Medicine Reports has found that the Bacillus-Calmette-Guerin (BCG) vaccine, ...

Please provide your email address to receive an email when new articles are posted on . Researchers observed the potential protective effect when accounting for death as a competing event. Patients ...

Published in The Lancet Global Health, the study found that BCG vaccination at birth does provide significant protection against TB disease -- but only among children under 5 years old. The vaccine ...

Bacillus Calmette-Guérin (BCG) vaccine is the live attenuated vaccine form of Mycobacterium bovis used to prevent tuberculosis and other mycobacterial infections. Now, using zebrafish “avatars,” a ...

A single injection of the 102-year-old tuberculosis vaccine, BCG, has proven effective at triggering an immune response in mice and shrank their liver cancer tumors, according to research by UC Davis ...

Bengaluru: In an effort to eliminate tuberculosis (TB) deaths in Karnataka, health minister Dinesh Gundu Rao Tuesday launched Adult BCG Vaccination Programme in 16 districts. The initiative is part of ...